Homatropini Methylbromidum
Homatropini Methylbromidum Uses, Dosage, Side Effects, Food Interaction and all others data.
Homatropini Methylbromidum is a quaternary ammonium muscarinic acetylcholine receptor antagonist belonging to the group of medicines called anti-muscarinics. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
Homatropini Methylbromidum belongs to the group of medicines called anti-muscarinics. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
| Trade Name | Homatropini Methylbromidum |
| Generic | Homatropine methylbromide |
| Homatropine methylbromide Other Names | Homatropine methylbromide, Homatropini methylbromidum, Méthylbromure d'homatropine, Methylhomatropine, Methylhomatropine bromide, Methylhomatropinum bromatum, Metilbromuro de homatropina, Omatropina metilbromuro, Tropinium methobromide mandelate |
| Type | |
| Formula | C17H24BrNO3 |
| Weight | Average: 370.281 Monoisotopic: 369.093956286 |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Homatropini Methylbromidum is a muscarinic receptor antagonist used to treat peptic ulcers, gastric ulcers, and duodenal ulcers.
Used in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcers, gastric ulcers and duodenal ulcers, to reduce further gastric acid secretion and delay gastric emptying.
Homatropini Methylbromidum is also used to associated treatment for these conditions: Cough
How Homatropini Methylbromidum works
Homatropine is a quaternary ammonium muscarinic acetylcholine receptor antagonist. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Homatropini Methylbromidum inhibits the muscarinic actions of acetylcholine on structures innervated by postganglionic cholinergic nerves as well as on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These postganglionic receptor sites are present in the autonomic effector cells of the smooth muscle, cardiac muscle, sinoatrial and atrioventricular nodes, and exocrine glands. Depending on the dose, anticholinergics may reduce the motility and secretory activity of the gastrointestinal system, and the tone of the ureter and urinary bladder and may have a slight relaxant action on the bile ducts and gallbladder.
Food Interaction
No interactions found.Innovators Monograph
You find simplified version here Homatropini Methylbromidum
